The Technical Analyst
IRadimed Corp [IRMD]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
IRadimed Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-0.99% $40.88
America/New_York / 15 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 517.66 mill |
| EPS: | 1.350 |
| P/E: | 30.28 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 12.66 mill |
| Avg Daily Volume: | 0.0551 mill |
| RATING 2024-04-15 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 30.28 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.14x |
| Company: PE 30.28 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$38.48 (-5.86%) $-2.40 |
| Date: 2024-04-16 |
| Expected Trading Range (DAY) |
|---|
|
$ 39.42 - 42.34 ( +/- 3.57%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-26 | Susi Roger E. | Sell | 5 000 | Common Stock |
| 2023-12-27 | Susi Roger E. | Sell | 5 000 | Common Stock |
| 2023-12-21 | Susi Roger E. | Sell | 300 000 | Common Stock |
| 2023-12-18 | Susi Roger E. | Sell | 5 000 | Common Stock |
| 2023-12-19 | Susi Roger E. | Sell | 5 000 | Common Stock |
| INSIDER POWER |
|---|
| -83.06 |
| Last 100 transactions |
| Buy: 59 851 | Sell: 665 743 |
Forecast:
16:00 - $40.88
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $40.88
Forecast 2: 16:00 - $40.88
Forecast 3: 16:00 - $40.88
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $40.88 (-0.99% ) |
| Volume | 0.0289 mill |
| Avg. Vol. | 0.0551 mill |
| % of Avg. Vol | 52.42 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IRMD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:33 | buy | $46.43 | N/A | Active |
|---|
IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Last 10 Buy Signals
Latest Press Releases
2024-03-13 16:30:00 - Press Release
Iradimed Corporation To Participate At The 36th Annual Roth Conference
Winter springs, fla., march 13, 2024 (globe newswire) -- iradimed corporation (the “company”) (nasdaq: irmd) today announced that roger susi, the company's president and chief executive officer, will present at the 36th annual roth conference in laguna niguel, ca.
2024-02-08 08:05:00 - Press Release
Iradimed Corporation Announces Fourth Quarter Of 2023 And Full Year Of 2023 Financial Results
Winter springs, fla., feb. 08, 2024 (globe newswire) -- iradimed corporation (the “company”) (nasdaq: irmd) announced today its financial results for the three months and year ended december 31, 2023. the company is a leader in the development of innovative magnetic resonance imaging (“mri”) medical devices and the only known provider of a non-magnetic intravenous (“iv”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during mri procedures.
2024-02-01 16:05:00 - Press Release
Iradimed Corporation To Hold 2023 Fourth Quarter Financial Results Conference Call On February 8th.
Winter springs, fla., feb. 01, 2024 (globe newswire) -- iradimed corporation (nasdaq: irmd) announced today that the company will release its 2023 fourth quarter financial results before the market opens on thursday, february 8, 2024. iradimed management will host a conference call the same day beginning at 9:00 a.m. eastern time to discuss those results and to answer questions.
2024-01-09 08:30:00 - Press Release
Iradimed Corporation Reports Unaudited Fourth Quarter And 2023 Revenue
Winter springs, fla., jan. 09, 2024 (globe newswire) -- iradimed corporation (the “company”) (nasdaq: irmd), a leader in developing innovative magnetic resonance imaging (‘mri”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended december 31, 2023. the fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% from the prior year.
2024-01-02 16:30:00 - Press Release
Iradimed Corporation To Present At The 42nd Annual J.p. Morgan Healthcare Conference
Winter springs, fla., jan. 02, 2024 (globe newswire) -- iradimed corporation (the “company”) (nasdaq: irmd), a leader in developing innovative magnetic resonance imaging (“mri”) compatible medical devices, today announced that the company will be participating in the upcoming 42nd annual j.p.
Latest News
2024-02-08 18:20:02 - Seeking Alpha
IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript
2024-02-01 16:05:00 - GlobeNewsWire
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.
2024-01-02 16:30:00 - GlobeNewsWire
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P.
2023-11-17 09:46:41 - Zacks Investment Research
5 Small Hidden Gems for the Rest of 2023
We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX.
2023-09-22 08:16:10 - Zacks Investment Research
4 Top Profitable Stocks to Invest in Using Net Income Ratio
NVIDIA (NVDA), iRadimed (IRMD), Perdoceo Education (PRDO) and Axcelis Technologies (ACLS) have been selected as the top picks with a high net income ratio.
2023-09-08 08:17:06 - Zacks Investment Research
Top 3 Profitable Stocks to Buy Now Using Net Income Ratio
iRadimed (IRMD), PulteGroup (PHM) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
2023-09-06 16:00:00 - GlobeNewsWire
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences.
2023-08-30 10:31:51 - Zacks Investment Research
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
iRadimed (IRMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
2023-08-23 09:01:08 - Zacks Investment Research
3 Top Profitable Stocks to Invest in Using Net Income Ratio
Perdoceo Education (PRDO), Boot Barn (BOOT) and iRadimed (IRMD) have been selected as the top picks with a high net income ratio.
2023-08-21 12:02:08 - Zacks Investment Research
Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?
Want to start the week ahead of the pack? Check out ‘Momentum Mondays,' where I cover the leading breakout stocks in the market, summarize the major events of the week ahead, and prepare investors for profitable trading.